Skip to content
BLACK BOOK
manufacturer✓ Verified☎ Contact on file

Alumis Inc.

Pharmaceutical Preparations · South San Francisco, CA, United States

  1. PrincipalsDavid M GoldsteinChief Scientific OfficerJohn R. SchroerChief Financial OfficerJorn DrappaChief Medical Officerand 6 more
  2. CompanyAlumis Inc.South San Francisco, CA, United States
  3. Phone line+1 (650) 231-6625General business
Request a quote

Alumis Inc. is an SEC-registered Nasdaq-listed company (ticker ALMS) classified under SIC 2834: Pharmaceutical Preparations.

Capabilities

✓ Pharmaceutical manufacturing
Evidence for each capability
  • Pharmaceutical manufacturing. SIC 2834 — Pharmaceutical Preparations — SEC EDGAR company submissions

People 9

Chief executive

Martin BablerPresident, CEO and Chairman

Chair & board

James B. TananbaumDirector (Board)
Srinivas AkkarajuDirector (Board)

Finance

John R. SchroerChief Financial Officer

Legal

Sanam PangaliChief Legal Officer
Everyone else on file (4)
David M GoldsteinChief Scientific Officer
Jorn DrappaChief Medical Officer
Mark Christopher BradleyChief Development Officer
Roy C. HardimanChief Business & Strategy Ofcr

Supplier profile

Production
Yes

Source timeline

  1. Record created from SEC EDGAR company submissions

    SEC EDGAR company submissions ↗
  2. John R. Schroer — Chief Financial Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  3. Jorn Drappa — Chief Medical Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  4. Mark Christopher Bradley — Chief Development Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  5. David M Goldstein — Chief Scientific Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗

Similar makers